Stroke Immunology: Mechanisms and Therapeutic Prospects
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 1688
Special Issue Editors
Interests: cerebrovascular disease; stroke; neuroinflammation; neurorepair
Special Issue Information
Dear Colleagues,
Stroke is a major cause of death and disability worldwide. Despite great advances in acute management due to improved recanalization strategies, greater symptom awareness and prompt intervention, the recanalization eligibility is still limited, and a large proportion of stroke patients remain disabled or die. Translational stroke research has focused on neuroprotection as a promising strategy alongside recanalization to limit tissue injury. However, out of more than 1000 putative neuroprotectants, none have reached the clinical setting and, with neurorehabilitation being the only available treatment beyond the acute phase, there is a flagrant need to enhance post-stroke recovery.
In recent years, stroke immunology has emerged as a promising field, placing emphasis on the inflammatory response as a key pathophysiological event contributing to tissue injury and repair. It is now known that stroke not only triggers a local neuroinflammatory response but also induces disturbances in systemic immune homeostasis, and common stroke risk factors are associated with inflammatory processes.
This Special Issue aims to provide mechanistic insights into the high complexity of local and systemic immune disturbances affecting the stroke pathogenesis and outcome and cover recent therapeutic advances targeting immune pathways after stroke. Authors are welcome to submit original research articles or topic reviews that expand our knowledge of stroke immunology.
Dr. Emmanuel Pinteaux
Dr. Alba Grayston-Morales
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stroke
- neuroimmunology
- neuroinflammation
- thromboinflammation
- blood-brain barrier
- glia
- immunomodulation